Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
1(9%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
8
73%
Ph not_applicable
3
27%

Phase Distribution

0

Early Stage

8

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
8(72.7%)
N/ANon-phased studies
3(27.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(10)

Detailed Status

Completed10
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 28 (72.7%)
N/A3 (27.3%)

Trials by Status

completed1091%
active_not_recruiting19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
PROCEDURE
Total Trials
11